An overview of the subject of biodegradable microcapsular drug delivery systems is presented from a polymer chemist's viewpoint. Various polymerization and microencapsulation techniques (including emulsion polymerization, interfacial polycondensation, suspension crosslinking, coacer vation/phase separation and solvent evaporation/extraction) suitable for the preparation of biodegradable microcapsules based on proteins, polysaccharides, polyesters, polyamides, or cyanoacrylates are described. Drug release from biodegradable microcapsules is discussed, and examples are presented to illus trate how the rate of drug release can be controlled by adjusting parameters such as microcapsule size, porosity, and crosslinking. Prospects of site-specific chemotherapy by means of passive and active targeting of microcapsular drug carriers are also analyzed.
Get full access to this article
View all access options for this article.
References
1.
Ehrlich, P.Collected Studies on Immunology. New York: Wiley, 2:42-47 (1906).
2.
Green, B.K. and L. Schleicher, U.S. Patent 2,800,457 (1953); B.K. Green, U.S. Patent 2,800,458 (1953).
3.
Lutz, B.PDN-Ch., 34(8):30 (1985).
4.
Cf. Quarterly lists published by the Journal of Microencapsulation , Taylor and Francis, London.
Arshady, R.Polym. Eng. Sci., 30: (in press) ( 1990).
9.
Cf. Nixon, J.R.Endeavour, New Series, 9(3):123 (1985); C. Chemtob, Labopharma-probl. Tech., 32(346):702 (1984 ).
10.
Deasy, P.B.Microencapsulation and Related Drug Processes. Basel: Marcel Dekker (1984).
11.
Ibrahim, A. , P. Couvreur, M. Roland and S. Speiser.J. Pharm. Pharmacol. , 35:59 ( 1983).
12.
Couvreur, P. , V. Lenaerts, A. Ibrahim, L. Grislain, L. Van Snick, P. Guiot, C. Verdun and F. Brasseur in Targeting of Drugs with Synthetic Systems. G. Gregoriadis, G. Senior and G. Poste, eds. N.Y.: Plenum Publ. Co., p. 147 (1986).
13.
Cf. Gardon, J.L.High Polymers, 29:143 (1977).
14.
Morgan, P.W. and S.L. Kwolek.J. Polym. Sci., 40:299 (1959).
Okoda, J., A. Kusai and S. Ueda.J. Microencapsulation, 2:163 (1985).
20.
Takenaka, H. , Y. Kamashima and S.Y. Lin.J. Pharm. Sci., 69:513 (1980).
21.
Madan, P.L. and S.R. Shanbhag.J. Pharm. Pharmacol., 30:65 (1978).
22.
Mathiowitz, E. and R. Langer.J. Control Release, 5:13 ( 1987).
23.
Cf. Lim, F. and R.D. Moss.J. Pharm. Sci., 70:351 (1981).
24.
Cf., Fukumori, Y., T. Fukuda, Y. Hanyu, Y. Takeuchi and Y. Oruko.Chem. Pharm. Bull. , 35:2949 (1987).
25.
Hill, H.S. and R.E. Pondel in Controlled Release Technologies, Method, Theory and Applications , Vol. 2. A. F. Kydonieus, ed. Boca Raton, FL: CRC Press, p. 134 (1980).
26.
Tice, T.R. and D.R. Cowsar.Pharm. Technol. (November 26, 1986).
27.
Higuchi, T.J. Pharm. Sci., 52:1145 (1963).
28.
Baker, R.W. and H.K. Lansdale in Controlled Release of Biologically Active Agents. A. C. Tanquary and R. E. Lacy, eds. New York:Plenum, p. 15 (1974).
29.
Guy, R.H., J. Hadgraft, I.W. Kellaway and M.J. Taylor.Int. J. Pharm., 11:199 (1982).
30.
Gupta, D.V.S. and R.E. Sparks, in Controlled Release of Bioactive Materials . R. Baker, ed. New York:Academic, p. 39 (1981).
31.
Sato, T., M. Kanko, H.G. Schroeder and P.P. DeLuca.Pharm. Res., 5:21 (1988).
32.
Juni, K., M. Nakano and M. Kubota.Int. J. Pharm., 4:25 (1986).
33.
Yapel, A., U.S. Patent 4,147,767 (1979).
34.
Sugebayashi, K., Y. Morimoto, T. Madai, Y. Kato, A. Hasegawa and T. Arita.Chem. Pharm. Bull. , 27:204 (1979).
Grislain, L. , P. Couvreur, V. Lenaerts, M. Roland, D. Deprez-Decumpeneere and P. Speiser.Int. J. Pharm. , 15:335 (1983).
38.
Tomlinson, E., J.J. Burger, E.M. Schoonderwoerd, J. Kuik, F.C. Schloetz, J.G. McVie and S.N. Mills.J. Pharm. Pharmacl. , 34:88 (1982).
39.
Davis, S.S. and L. Illum.Brit. Polym. J., 15:160 (1983).
40.
Mosbach, K. and U. Schroeder.FEBS Letters, 102:112 (1979); T. Kato, R. Nemoto, H. Mori, S. Sato, K. Unno, M. Honma, M. Okada and T. Minova, IRCS Med. Sci., 7:621 (1979).
41.
Levy, R. and R.A. Miller.Fed. proc., 42:2650 (1983).
42.
Illum, L., P.D.E. Jones, J. Kreuter, R.W. Baldwin and S.S. Davis.Int. J. Pharm., 17:165 (1983);
43.
C. Kubiak, L. Manil and P. Couvreur, Int. J. Pharm., 41:181 (1988).
44.
For a review see P. Machy and L. Lerman, Liposomes, (English translation by D. Jarvis), John Libby Eurotext, Paris and London, 1987.
Leu, D., Ph.D. Thesis, Institute of Pharmacy, ETH- Zurich (1982).
50.
Leu, D., B. Manthey, J. Kreuter, P. Speiser and R.P. DeLuca.J. Pharm. Sci., 73:1433 (1984).
51.
Illum, L. and S.S. Davis.J. Pharm. Sci., 72:1086 (1983).
52.
Illum, L. and S.S. Davis.FEBS Letters, 167:79 (1984).
53.
Technical data on "Pluronic Polyols" and "Tetronic Polyols," BASF Wyandotte Corp., Parsippany, NY 07054.
54.
Davis, S.S., S.J. Douglas, L. Illum, P.D.E. Jones, E. Mak and R.H. Muller, in Targeting of Drugs with Synthetic Systems. G. Gregoriadis, G. Senior and G. Poste, eds. New York: Plenum, p. 123 ( 1986).
